C.E. Unterberg, Towbin Release: 100 Specialty Pharma, Medical Device And Biotechnology Growth Companies To Tell Their Stories And Discuss Their Innovations And Products On New York City October 25 And 26

NEW YORK, Oct. 18 /PRNewswire/ -- Nearly 100 publicly traded emerging- growth companies in the specialty pharmaceutical, medical device and biotechnology industries will make presentations, tell their stories and discuss their prospects at the C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference, which takes place Tuesday, October 25, and Wednesday, October 26, 2005 here, at the New York Palace Hotel.

C.E. Unterberg, Towbin is the investment bank focused on emerging growth opportunities in the technology, healthcare and global security industries.

Media are invited to attend. For more information, please contact Adria Greenberg at Sommerfield Communications, Inc. at 212-255-8386 or adria@sommerfield.com

WHAT: C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference WHO: Leaders of nearly 100 publicly traded emerging growth companies in the specialty pharmaceutical, medical device and biotechnology industries discussing their innovations, strategies and prospects with institutional investors WHEN: Tuesday, October 25, 2005, from 7:00 a.m. until 5:00 p.m., and Wednesday, October 26, from 7:00 a.m. until 5:00 p.m. WHERE: New York Palace Hotel, 455 Madison Avenue at 50th Street, New York, New York. CONTACT: To attend, and for more information, please contact Adria Greenberg at Sommerfield Communications, Inc. at 212-255-8386 or adria@sommerfield.com

C.E. Unterberg, Towbin

CONTACT: Adria Greenberg of Sommerfield Communications, Inc., +1-212-255-8386, or adria@sommerfield.com

MORE ON THIS TOPIC